Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry

Academic Medicine

Volumn 82, Issue 1, 2007, Pages 94-99

  Hyman, Paul L ^a,e   Hochman, Michael E ^b   Shaw, Jonathan G ^c   Steinman, Michael A ^d  

^a Harvard Combined Medicine Pediatrics Residency   (United States)

^b Cambridge City Hospital   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; HEALTH SURVEY; HUMAN; MEDICAL STUDENT; PRIORITY JOURNAL; STUDENT ATTITUDE;

EID: 33845968525     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ACM.0000249907.88740.ef     Document Type: Article

References (24)

1. Wazana A. Gifts to physicians from the pharmaceutical industry. JAMA. 2000;283:2655-2658.
2. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351:1885-1890.
3. Angell M. The Truth about Drug Companies: How They Deceive Us and What to Do About It. New York: Random House; 2004.
4. Avorn J. Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. New York: Knopf; 2004.
5. Kassirer J. On the Take: How Medicine's Complicity with Big Business Can Endanger Your Health. New York: Oxford University Press; 2005.
6. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295:429-433.
7. Sierles FS, Brodkey AC, Cleary LM, et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294:1034-1042.
8. Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med. 2006;81:154-160.
9. Pollack A. Stanford to ban drug makers' gifts to doctors, even pens. New York Times. September 12, 2006; sect C:2.
10. Monaghan MS, Galt KA, Turner PD, et al. Student understanding of the relationship between the health professions and the pharmaceutical industry. Teach Learn Med. 2003;15:14-20.
11. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. CMAJ. 1995;153:553-559.
12. Sandberg WS, Carlos R, Sandberg EH, Roizen MF. The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products. Acad Med. 1997;72:916-918.
13. Bellin M, McCarthy S, Drevlow L, Pierach C. Medical students' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med. 2004;79:1041-1045.
14. Fischer C, Shashaty E, Watkins D, Lurie P, Wolfe S. A survey of medical students' attitudes and practices regarding gifts from pharmaceutical companies [abstract]. J Gen Intern Med. 2003;18(suppl 1):247.
15. Barfett J, Lanting B, Lee J, Lee M, Ng V, Simkhovitch P. Pharmaceutical marketing to medical students: the student perspective. McGill J Med. 2004;8:21-27.
16. Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med. 2006;81:595-602.
17. Brotzman GL, Mark DH. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993;8:130-134.
18. McCormick GL, Tomlinson G, Brill-Edwards P, Detsky AS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286:1994-1999.
19. Vinson DC, McCandless B, Hosokawa MC. Medical students' attitudes toward pharmaceutical marketing: possibilities for change. Fam Med. 1993;25:31-33.
20. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med. 2001;76:1271-1277.
21. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-557.
22. Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. A thematic review. J Gen Intern Med. 2005;20:777-786.
23. Shaughnessy AF, Slawson DC, Bennet JH. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med. 1995;27:581-585.
24. American Medical Student Association. Principles regarding pharmaceuticals and medical devices. Available at: (http://www.amsa.org/hp/ pharmpolicy.cfm). Accessed January 24, 2006. Reston, VA; 2005.